Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for PSNL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 38.16M
March 31, 2026 -46.01M
December 31, 2025 -14.38M
September 30, 2025 18.72M
June 30, 2025 -4.371M
March 31, 2025 -22.54M
December 31, 2024 -26.18M
September 30, 2024 -28.18M
June 30, 2024 12.99M
March 31, 2024 6.301M
December 31, 2023 -11.64M
September 30, 2023 -8.605M
June 30, 2023 19.55M
March 31, 2023 13.79M
December 31, 2022 21.85M
September 30, 2022 10.83M
June 30, 2022 23.02M
Date Value
March 31, 2022 -3.161M
December 31, 2021 39.91M
September 30, 2021 29.67M
June 30, 2021 -47.10M
March 31, 2021 -82.54M
December 31, 2020 -63.14M
September 30, 2020 5.647M
June 30, 2020 -7.615M
March 31, 2020 -0.035M
December 31, 2019 -34.85M
September 30, 2019 -43.93M
June 30, 2019 -1.841M
March 31, 2019 -0.96M
December 31, 2018 -0.671M
September 30, 2018 -1.944M
June 30, 2018 -3.928M
March 31, 2018 -1.309M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Tempus AI, Inc. -11.09M
10X Genomics, Inc. -7.735M
Alamar Biosciences, Inc. (California) -120.80M
Adaptive Biotechnologies Corp. -43.48M
Champions Oncology, Inc. -0.238M